Cargando…
Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth
The laminin-binding glycan (matriglycan) on α-dystroglycan (α-DG) enables diverse roles, from neuronal development to muscle integrity. Reduction or loss of matriglycan has also been implicated in cancer development and metastasis, and specifically associated with high-grade tumors and poor prognose...
Autores principales: | Lu, Pei J., Tucker, Jason D., Branch, Elizabeth K., Guo, Fei, Blaeser, Anthony R., Lu, Qi L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080755/ https://www.ncbi.nlm.nih.gov/pubmed/32188898 http://dx.doi.org/10.1038/s41598-020-61747-z |
Ejemplares similares
-
The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition
por: Praissman, Jeremy L, et al.
Publicado: (2016) -
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019) -
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice
por: Cataldi, Marcela P., et al.
Publicado: (2018) -
Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model
por: Wu, Bo, et al.
Publicado: (2022) -
Identification of Matriglycan by Dual Exoglycosidase Digestion of α-Dystroglycan
por: Chandel, Ishita, et al.
Publicado: (2023)